Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

RFID’s Possible Interaction With Biologics Queried By Biogen, Pfizer

Executive Summary

Radiofrequency identification appears to hold the most potential to increase the security of the pharmaceutical supply chain, stakeholders advise FDA, but important questions include how the radiofrequency emissions might interact with biologics and certain other kinds of drug products

You may also be interested in...



EU Tackles Counterfeits, But Parallel Trade Poses Tough Issues

Tackling counterfeit drugs is one pillar of the European Commission's package of new proposed pharmaceutical legislation. It will mean higher costs for most drug firms, while significant loopholes will remain

EU Tackles Counterfeits, But Parallel Trade Poses Tough Issues

Tackling counterfeit drugs is one pillar of the European Commission's package of new proposed pharmaceutical legislation. It will mean higher costs for most drug firms, while significant loopholes will remain

RFID tracking and privacy workshop

Emerging uses of radiofrequency identification technology and implications for consumer protection is the subject of a Sept. 23 workshop being convened by Federal Trade Commission staff. The session will bring together industry, government and consumer representatives from Europe and the U.S. to discuss security and privacy concerns associated with RFID. The technology is seen by some drug makers as having the potential to increase security of the pharmaceutical supply chain, and the growing utilization of item-level tagging in the retail sector is on the agenda (1"The Pink Sheet," June 16, 2008, p. 16)

Related Content

Latest News
See All
UsernamePublicRestriction

Register

PS049765

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel